FI964619A - Epilepsialääkkeiden iholle annostelu - Google Patents

Epilepsialääkkeiden iholle annostelu Download PDF

Info

Publication number
FI964619A
FI964619A FI964619A FI964619A FI964619A FI 964619 A FI964619 A FI 964619A FI 964619 A FI964619 A FI 964619A FI 964619 A FI964619 A FI 964619A FI 964619 A FI964619 A FI 964619A
Authority
FI
Finland
Prior art keywords
dosage
skin
antiepileptic drugs
antiepileptic
drugs
Prior art date
Application number
FI964619A
Other languages
English (en)
Swedish (sv)
Other versions
FI964619A0 (fi
Inventor
Helle Weibel
Peter Bonne Eriksen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8095138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI964619(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI964619A0 publication Critical patent/FI964619A0/fi
Publication of FI964619A publication Critical patent/FI964619A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI964619A 1994-05-20 1996-11-19 Epilepsialääkkeiden iholle annostelu FI964619A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK57794 1994-05-20
PCT/DK1995/000194 WO1995031976A1 (en) 1994-05-20 1995-05-17 Transdermal delivery of anti-epileptic drugs

Publications (2)

Publication Number Publication Date
FI964619A0 FI964619A0 (fi) 1996-11-19
FI964619A true FI964619A (fi) 1996-11-19

Family

ID=8095138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964619A FI964619A (fi) 1994-05-20 1996-11-19 Epilepsialääkkeiden iholle annostelu

Country Status (20)

Country Link
US (1) US5750140A (fi)
EP (1) EP0760656A1 (fi)
JP (1) JPH10500415A (fi)
KR (1) KR970703146A (fi)
CN (1) CN1148806A (fi)
AU (1) AU698131B2 (fi)
BR (1) BR9507736A (fi)
CA (1) CA2190837C (fi)
CZ (1) CZ338196A3 (fi)
FI (1) FI964619A (fi)
HU (1) HUT75864A (fi)
IL (1) IL113793A (fi)
NO (1) NO964915D0 (fi)
NZ (1) NZ287012A (fi)
PE (1) PE2596A1 (fi)
RU (1) RU2152784C1 (fi)
SK (1) SK281076B6 (fi)
TW (1) TW372875B (fi)
WO (1) WO1995031976A1 (fi)
ZA (1) ZA954118B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
US6537537B2 (en) 1997-06-12 2003-03-25 The Procter & Gamble Company Water-in-silicone emulsion cosmetic compositions
GB9712272D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
GB9712271D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
US6316010B2 (en) 1997-06-12 2001-11-13 The Procter & Gamble Company Cosmetic compositions
GB9712269D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
DK0991409T3 (da) * 1997-08-01 2002-03-25 Elan Corp Plc Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
CA2479672A1 (en) * 2002-03-18 2003-10-02 Roger K. Cady Preemptive prophylaxis of migraine
PL3474820T3 (pl) 2017-08-24 2024-05-13 Novo Nordisk A/S Kompozycje glp-1 i ich zastosowania
TW202140063A (zh) 2020-02-18 2021-11-01 丹麥商諾佛 儂迪克股份有限公司 醫藥配方

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling

Also Published As

Publication number Publication date
AU2559995A (en) 1995-12-18
NO964915L (no) 1996-11-19
PE2596A1 (es) 1996-02-12
WO1995031976A1 (en) 1995-11-30
BR9507736A (pt) 1997-08-19
CA2190837A1 (en) 1995-11-30
US5750140A (en) 1998-05-12
KR970703146A (ko) 1997-07-03
JPH10500415A (ja) 1998-01-13
RU2152784C1 (ru) 2000-07-20
CN1148806A (zh) 1997-04-30
ZA954118B (en) 1996-11-19
AU698131B2 (en) 1998-10-22
IL113793A0 (en) 1995-08-31
HUT75864A (en) 1997-05-28
CZ338196A3 (en) 1997-06-11
NZ287012A (en) 1998-09-24
NO964915D0 (no) 1996-11-19
EP0760656A1 (en) 1997-03-12
CA2190837C (en) 2005-08-02
SK281076B6 (sk) 2000-11-07
FI964619A0 (fi) 1996-11-19
HU9603206D0 (en) 1997-01-28
TW372875B (en) 1999-11-01
SK148296A3 (en) 1997-06-04
IL113793A (en) 1999-12-31

Similar Documents

Publication Publication Date Title
DK0783302T3 (da) Lægemidler
NO942923L (no) Medikamenter
FI932655A (fi) Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
MA26549A1 (fr) Medicaments
KR950700754A (ko) 신규의 약물(novel medicament)
NO930677L (no) Farmasoeytiske forbindelser
FI965204A0 (fi) Bromelaiinin lääkekäyttö
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu
BR9600809A (pt) Medicamento
BR9508339A (pt) Medicamento
NO931008D0 (no) Farmasoeytiske forbindelser
FI942400A0 (fi) Lääkeaine hermosairauksia vastaan
FI955605A0 (fi) Aryloivia lääkkeitä
NO974529D0 (no) Innretning for tilförselen av alfuzosin gjennom huden
FI951155A0 (fi) Farmaseuttinen valmiste
DE59610423D1 (de) Partikulare arzneiform
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
KR970000449U (ko) 일회용 주사기
SE9401674L (sv) Läkemedel
NO944330D0 (no) Legemiddel
SE9402131D0 (sv) Läkemedel
TH13625EX (th) เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท
SE9402432D0 (sv) New pharmaceutical dosage form
ATE239508T1 (de) Partikulare arzneiform
IT234192Y1 (it) Dispositivo per la medicazione di lesioni cutanee